Organon (OGN) Retained Earnings (2020 - 2026)

Organon (OGN) recorded quarterly Retained Earnings of -$539.0 million in Q1 2026, down 148.6% quarter-over-quarter from $1.1 billion in Q4 2025, and down 152.53% on a YoY basis from $1.0 billion in Q1 2025.

Organon (OGN) Retained Earnings (2020 - 2026) Analysis & Trends

Organon's Retained Earnings history runs 7 years deep, the most recent figure standing at -$539.0 million for Q1 2026.

  • In Q1 2026, Retained Earnings fell 152.53% year-over-year to -$539.0 million; the TTM figure through Mar 2026 stood at -$539.0 million (down 152.53% YoY), while the FY2025 annual figure was $1.1 billion, up 270.88% from the prior year.
  • Retained Earnings was -$539.0 million for Q1 2026 at Organon, down from $1.1 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $1.3 billion in Q3 2025 to a low of -$649.0 million in Q4 2024.
  • Historically, Retained Earnings has averaged -$28.9 million across 5 years, with a median of -$529.0 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Retained Earnings slumped 3468.75% in 2024, then soared 330.82% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$564.0 million in 2022, then soared by 178.55% to $443.0 million in 2023, then sank by 246.5% to -$649.0 million in 2024, then soared by 270.88% to $1.1 billion in 2025, then sank by 148.6% to -$539.0 million in 2026.
  • The last three Retained Earnings figures came in at -$539.0 million (Q1 2026), $1.1 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn 1.90 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 29.51 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn -14.83 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -17.87 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 66.72 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn -190.00 Mn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 78.00 Mn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn -7.20 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn -1.37 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn -539.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -539.00 Mn
Dec 31, 2025 1.11 Bn
Sep 30, 2025 1.32 Bn
Jun 30, 2025 1.16 Bn
Mar 31, 2025 1.03 Bn
Dec 31, 2024 -649.00 Mn
Sep 30, 2024 -571.00 Mn
Jun 30, 2024 -612.00 Mn
Mar 31, 2024 -577.00 Mn
Dec 31, 2023 443.00 Mn
Sep 30, 2023 -16.00 Mn
Jun 30, 2023 -25.00 Mn
Mar 31, 2023 -534.00 Mn
Dec 31, 2022 -564.00 Mn
Sep 30, 2022 -383.00 Mn
Jun 30, 2022 -551.00 Mn
Mar 31, 2022 -529.00 Mn
Dec 31, 2021 -513.00 Mn
Sep 30, 2021 -493.00 Mn
Jun 30, 2021 81.00 Mn